By the Numbers

National Celiac Disease Awareness Day: 7 updates on diagnosis, therapies

September 13 is recognized as National Celiac Disease Awareness Day, a day set aside to educate the public and raise awareness about the disease.

Celiac affects an estimated 3 million Americans, and many more individuals remain undiagnosed or misdiagnosed. The only current treatment for the disease is a gluten-free diet, which must be adhered to for life.

To mark National Celiac Disease Awareness Day, Healio Gastroenterology and Liver Disease compiled seven recent news updates on recent advances in research on celiac disease and other gluten-related conditions.

1. New drug may protect celiac patients from inadvertent gluten exposure

An experimental biologic drug showed promise for reducing symptoms and inflammation in patients with celiac disease following gluten exposure, according to data from a phase 2 proof-of-concept study released in advance of DDW 2018. READ MORE

2. IL-15 inhibitor shows promise in halting progression of refractory celiac disease type II

AMG 715, an investigational anti-interleukin 15 inhibitor, showed safety and efficacy for stopping the progression of refractory celiac disease type II, according to phase 2 randomized controlled trial data presented at DDW 2018. READ MORE

3. Celiac diagnosis takes longer for patients without GI symptoms

Patients with celiac disease can have their diagnosis delayed by about 3.5 years if they do not have gastrointestinal symptoms, according to research published in The American Journal of Medicine. READ MORE

4. Undiagnosed celiac disease more common in women

Women in the general population are more likely to have undiagnosed celiac disease, and the difference is even more pronounced in younger girls, according to data presented at DDW 2018. READ MORE

5. True Health launches new test for celiac, gluten sensitivity

True Health has announced that it will offer new comprehensive testing for celiac disease and gluten sensitivity. The test will provide physicians with information about the specific cause of their patients’ symptoms reported as gluten sensitivity. READ MORE

6. Non-celiac w heat s ensitivity : Emerging from the s hadow of c eliac d isease

Non-celiac gluten sensitivity (NCGS) has lived in celiac’s shadow for years, and despite an increase in research on the condition during the last decade, many questions remain about its cause, its prevalence and how to diagnose it. READ MORE

7. Eosinophil infiltration could influence non-celiac wheat sensitivity

The presence of duodenal and rectal eosinophils could help clinicians diagnose patients with non-celiac wheat sensitivity, according to research published in Clinical Gastroenterology and Hepatology. READ MORE

September 13 is recognized as National Celiac Disease Awareness Day, a day set aside to educate the public and raise awareness about the disease.

Celiac affects an estimated 3 million Americans, and many more individuals remain undiagnosed or misdiagnosed. The only current treatment for the disease is a gluten-free diet, which must be adhered to for life.

To mark National Celiac Disease Awareness Day, Healio Gastroenterology and Liver Disease compiled seven recent news updates on recent advances in research on celiac disease and other gluten-related conditions.

1. New drug may protect celiac patients from inadvertent gluten exposure

An experimental biologic drug showed promise for reducing symptoms and inflammation in patients with celiac disease following gluten exposure, according to data from a phase 2 proof-of-concept study released in advance of DDW 2018. READ MORE

2. IL-15 inhibitor shows promise in halting progression of refractory celiac disease type II

AMG 715, an investigational anti-interleukin 15 inhibitor, showed safety and efficacy for stopping the progression of refractory celiac disease type II, according to phase 2 randomized controlled trial data presented at DDW 2018. READ MORE

3. Celiac diagnosis takes longer for patients without GI symptoms

Patients with celiac disease can have their diagnosis delayed by about 3.5 years if they do not have gastrointestinal symptoms, according to research published in The American Journal of Medicine. READ MORE

4. Undiagnosed celiac disease more common in women

Women in the general population are more likely to have undiagnosed celiac disease, and the difference is even more pronounced in younger girls, according to data presented at DDW 2018. READ MORE

5. True Health launches new test for celiac, gluten sensitivity

True Health has announced that it will offer new comprehensive testing for celiac disease and gluten sensitivity. The test will provide physicians with information about the specific cause of their patients’ symptoms reported as gluten sensitivity. READ MORE

6. Non-celiac w heat s ensitivity : Emerging from the s hadow of c eliac d isease

Non-celiac gluten sensitivity (NCGS) has lived in celiac’s shadow for years, and despite an increase in research on the condition during the last decade, many questions remain about its cause, its prevalence and how to diagnose it. READ MORE

7. Eosinophil infiltration could influence non-celiac wheat sensitivity

The presence of duodenal and rectal eosinophils could help clinicians diagnose patients with non-celiac wheat sensitivity, according to research published in Clinical Gastroenterology and Hepatology. READ MORE

    See more from By the Numbers